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Dear Editor,
Recently, three female patients with a migratory background
(Surinam, Afghanistan and Turkey) presented in our hospital with signs
of an anaphylactic shock due to a spontaneous Echinococcus granulosus
cyst rupture. Although the current literature states that serology for
Cystic Echinococcosis (CE) should be positive in these patients [1,2],
serology was found to be negative in all three patients at presentation.
This prompted us to review the literature, which resulted in a hy-
pothesis that could explain the false negative serology in patients with
anaphylaxis due to CE.
1. False negative serology in anaphylactic patients with cystic
echinococcosis
CE is a severe zoonotic disease caused by the cestode species
Echinococcus granulosus and is mainly seen in patients originating from
endemic areas such as the Mediterranean countries, China, South
America and North and East Africa [2]. Patients develop large cysts
filled with numerous protoscolices and hence Echinococcus antigens [2].
Upon rupture of these cysts, cyst contents are released and may cause
anaphylaxis, which was recently experienced by three patients in our
hospital. The cyst location in these patients was hepatic (twice) and
pulmonic, as determined by imaging. Specific antibodies for CE were
absent in all three CE patients in samples collected at the time of pre-
sentation. However, specific antibodies were present in samples taken
≥6 days after admission (Fig. 1A). Because CE was already suspected,
all three patients were treated with albendazole from the acute pre-
sentation onwards and they all made a full recovery. However, if the
negative serology would have resulted in a wait and see policy, sec-
ondary CE could have developed, causing severe problems.
1.1. Mechanism of false negative serology
We postulate the following mechanism for the false negative ser-
ological results when patients are in an anaphylactic state (Fig. 1B).
Massive antigen release and the subsequently formed antibody-antigen
complexes are thought to evoke the anaphylactic reaction. Upon cyst
rupture, antigens are abruptly and excessively released in the cyst en-
vironment, which will saturate all (or a substantial part of) the avail-
able specific antibodies if there is access to the circulation. The ana-
phylactic symptoms of the patients showed that in our cases this route
was accessible. In serological assays the presence of specific antibodies
is tested through their capability to bind to specific antigens. However,
if the specific antibodies have already bound released antigens in the
circulation of the patient, these specific antibodies are saturated and
have become non-reactive in serological assays. As a consequence, a
(false) negative test result will be obtained. The proposed mechanism is
different from the “prozone effect”, in which the excess of either anti-
gens or antibodies in the assay results in decreased reactivity [3]. In our
case the antibodies in the blood sample have bound antigen from the
ruptured cyst, thereby rendering dilution, the normal method to curb
the prozone effect, ineffective.
2. Conclusions
We proposed a mechanism that explains false-negative serology in
patients with a ruptured Echinococcus cyst that are experiencing ana-
phylactic shock. Therefore, when initial serological results are negative
and a ruptured CE cyst is suspected, we advise to repeat CE serology
after at least a week before ruling out CE as the cause of the anaphy-
lactic shock.
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Fig. 1. Panel A: Echinococcus specific IgG levels over time of
the three presented cases. The dashed line at 15 U/ml re-
presents the cut-off point. E. granulosus specific antibodies
were determined with the SERION ELISA classic
Echinococcosis IgG test [4]. For two of the three patients the
negative as well as the subsequent positive serological re-
sults were confirmed by two other methods; a commercially
available Indirect Haem Agglutination assay (IHA, Fu-
mouze) and an in-house developed ELISA. For one patient,
no material was left for retrospective confirmation. Panel B:
Proposed mechanism of false-negative serology results in
serum collected at presentation of patients with an ana-
phylactic reaction. In a predisposed individual with high IgE
(1), release of antigen through cystic echinococcosis cyst
rupture (2) may result in abundant release of antigens into
the bloodstream (3), which will bind to all available free
and mast-cell bound IgE (4). This will result in release of
inflammatory mediators by mast cells, causing anaphylaxis
(5). Simultaneously, the antigen-antibody complexes will
not bind to antigens provided in the serological assay, re-
sulting in false negative results (6).
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